Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (757), Vomiting
...CenterWatch: New Medical Therapies in Disease Category (757), Vomiting Vomiting Patient Medical Areas • Gastroenterology December 1, 2006 Prostrakan reported positive results from a phase III ...
View Page

2.  CenterWatch: Clinical Trials in Category (757) Vomiting
...CenterWatch: Clinical Trials in Category (757) Vomiting Vomiting State • Georgia Georgia Savannah : Memorial Health University Medical Center Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron ...
View Page

3. Clinical Trial Results: Post-Operative Nausea and Vomiting
...Clinical Trial Results: Post-Operative Nausea and Vomiting Clinical Trial Results: Post-Operative Nausea and Vomiting Product Name: Kytril [granisetron] Date of Report: 6/30/2004 Phase: IV A prospective, randomized ...
View Page

4. Clinical Trial Results by Drug Names
...Result Information Title of Study: Intravenous granisetron (Kytril) in the prevention of postoperative nausea and vomiting (PONV) in pediatric subjects undergoing tonsillectomy or adenotonsillectomy Fast Facts: Protocol number: ML16633 Sponsor: Roche ...
...name: granisetron hydrochloride Phase of development: IV Therapeutic area, approved indication: Post-Operative Nausea and Vomiting Date of report: 6/2/2008 Clinical study summary: This was a multicenter, randomized, double ...
View Page

5. Clinical Trial Results by Drug Names
...granisetron plus dexamethasone vs ondansetron plus dexamethasone in the prevention of post-operative nausea and vomiting in patients undergoing abdominal hysterectomy Fast Facts: Protocol number: ML17517 Sponsor: Roche Laboratories Inc. Company ...
...Generic name: granisetron Phase of development: IV Therapeutic area, approved indication: Post-Operative Nausea and Vomiting Date of report: 6/30/2004 Clinical study summary: This multicenter, randomized, double-blind, parallel ...
View Page

6.  Study Posting (4519) Trial #123636, Surgery, Dallas, TX
...Trial Information A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy Status: Completed Protocol Number: ML16633 Sponsor: Hoffmann ...
...study of 2 dose levels of Kytril on the prevention of post-operative nausea and vomiting in pediatric patients undergoing surgery with general anesthesia Brief Summary: This 2 arm study will ...
View Page

7.  Study Posting (4519) Trial #124191, Surgery, Nashville, TN
...Trial Information A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy Status: Completed Protocol Number: ML16633 Sponsor: Hoffmann ...
...study of 2 dose levels of Kytril on the prevention of post-operative nausea and vomiting in pediatric patients undergoing surgery with general anesthesia Brief Summary: This 2 arm study will ...
View Page

8.  Study Posting (4519) Trial #124460, Surgery, Pittsburgh, PA
...Trial Information A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy Status: Completed Protocol Number: ML16633 Sponsor: Hoffmann ...
...study of 2 dose levels of Kytril on the prevention of post-operative nausea and vomiting in pediatric patients undergoing surgery with general anesthesia Brief Summary: This 2 arm study will ...
View Page

9.  Study Posting (4519) Trial #126701, Surgery, Boston, MA
...Trial Information A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy Status: Completed Protocol Number: ML16633 Sponsor: Hoffmann ...
...study of 2 dose levels of Kytril on the prevention of post-operative nausea and vomiting in pediatric patients undergoing surgery with general anesthesia Brief Summary: This 2 arm study will ...
View Page

10.  Study Posting (4519) Trial #124156, Surgery, Miami, FL
...Trial Information A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy Status: Completed Protocol Number: ML16633 Sponsor: Hoffmann ...
...study of 2 dose levels of Kytril on the prevention of post-operative nausea and vomiting in pediatric patients undergoing surgery with general anesthesia Brief Summary: This 2 arm study will ...
View Page

11.  Study Posting (4519) Trial #124396, Surgery, Stanford, CA
...Trial Information A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy Status: Completed Protocol Number: ML16633 Sponsor: Hoffmann ...
...study of 2 dose levels of Kytril on the prevention of post-operative nausea and vomiting in pediatric patients undergoing surgery with general anesthesia Brief Summary: This 2 arm study will ...
View Page

12.  Study Posting (4519) Trial #123927, Surgery, Fresno, CA
...Trial Information A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy Status: Completed Protocol Number: ML16633 Sponsor: Hoffmann ...
...study of 2 dose levels of Kytril on the prevention of post-operative nausea and vomiting in pediatric patients undergoing surgery with general anesthesia Brief Summary: This 2 arm study will ...
View Page

13.  Newly Approved Drug Therapies (713) Kytril (granisetron) solution, Roche,
...Name: Kytril (granisetron) solution Company: Roche Approval Status: Approved June 2001 Treatment Area: Nausea and vomiting associated with cancer therapy General Information Subjects receiving chemotherapy and radiation therapy can suffer from severe nausea and vomiting as side effects to cancer treatment. Kytril solution has been approved for the prevention of ...
View Page

14.  Newly Approved Drug Therapies (998) Sancuso (granisetron), ProStrakan,
...Sancuso (granisetron) Company: ProStrakan Approval Status: Approved September 2008 Treatment Area: chemotherapy-induced nausea and vomiting General Information Sancuso is a transdermal elective 5-hydroxytryptamine3 (5-HT3) receptor antagonist with little or no affinity for other serotonin receptors. During chemotherapy that induces vomiting, mucosal enterochromaffin cells release serotonin, which stimulates 5-HT3 receptors. The 5-HT3 antagonists prevent ...
View Page

15.  CenterWatch: Clinical Trials in Category (614) Surgery
...Research Site: A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy Stanford : Research Site: A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy Florida Fort Lauderdale : Holy Cross Hospital Research ...
View Page

16.  Study Posting (4128) Trial #84712, Testicular Cancer, Portland, OR
...Assess the Safety and Efficacy of Aloxi® (Palonosetron HCI) for the Prevention of Nausea and Vomiting in Patients Receiving Consecutive Daily Doses of Cisplatin Therapy for Testicular Cancer The purpose of ...
...find out what effects (good or bad) palonosetron (Aloxi®) can have on the nausea and vomiting caused by testicular cancer chemotherapy treatment. The Food and Drug Administration (FDA) approved palonosetron in ...
View Page

17.  Study Posting (4128) Trial #84713, Testicular Cancer, Cleveland, OH
...Assess the Safety and Efficacy of Aloxi® (Palonosetron HCI) for the Prevention of Nausea and Vomiting in Patients Receiving Consecutive Daily Doses of Cisplatin Therapy for Testicular Cancer The purpose of ...
...find out what effects (good or bad) palonosetron (Aloxi®) can have on the nausea and vomiting caused by testicular cancer chemotherapy treatment. The Food and Drug Administration (FDA) approved palonosetron in ...
View Page

18.  Study Posting (4128) Trial #84197, Testicular Cancer, Indianapolis, IN
...Assess the Safety and Efficacy of Aloxi® (Palonosetron HCI) for the Prevention of Nausea and Vomiting in Patients Receiving Consecutive Daily Doses of Cisplatin Therapy for Testicular Cancer The purpose of ...
...find out what effects (good or bad) palonosetron (Aloxi®) can have on the nausea and vomiting caused by testicular cancer chemotherapy treatment. The Food and Drug Administration (FDA) approved palonosetron in ...
View Page

19.  Study Posting (1918) Trial #160138, Vomiting, Savannah, GA
...Study Posting (1918) Trial #160138, Vomiting, Savannah, GA Trial Information Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Patients ...
...Aprepitant, and Palonosetron in Preventing Nausea in Patients Undergoing Chemotherapy for Breast Cancer URCC U1105 Vomiting Savannah, GA 160138 Clinical Trial Participation If you would like to learn more about participating ...
View Page

20.  Newly Approved Drug Therapies (331) Kytril (granisetron) tablets, SmithKline Beecham,
...Kytril (granisetron) tablets Company: SmithKline Beecham Approval Status: Approved November 1997 Treatment Area: nausea and vomiting associated with chemotherapy General Information A single 2 mg dose of Kytril (granisetron hydrochloride) has been approved for the treatment of nausea and vomiting associated with chemotherapy. Until now, the recommended dosage for Kytril tablets was one 1 mg ...
View Page